Laboratory aspects of circulating α-Klotho

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2283-2287

  Heijboer, Annemieke C ^a   Blankenstein, Marinus A ^a   Hoenderop, Joost ^b   De Borst, Martin H ^c   Vervloet, Marc G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Klotho; Analytical validation; Immunoassays; Standardization

Indexed keywords

ALPHA KLOTHO PROTEIN; EDETIC ACID; KLOTHO PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BETWEEN RUN VARIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IMMUNOASSAY; INTERMETHOD COMPARISON; LINEARITY; MATRIX EFFECT; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUALITY CONTROL; RECOVERY; STANDARDIZATION; WITHIN RUN VARIATION;

ANALYTICAL VALIDATION; IMMUNOASSAYS; STANDARDIZATION; Α-KLOTHO;

BIOLOGICAL ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCURONIDASE; HUMANS; KIDNEY;

EID: 84884511275     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft236     Document Type: Article

References (22)

1. Farrow EG, Davis SI, Summers LJ et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20: 955-960
2. Vervloet MG, Larsson TE. Fibroblast growth factor-23 and Klotho in chronic kidney disease. Kidney Int 2011; 1: 130-135
3. Chang Q, Hoefs S, van der Kemp AW et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005; 310: 490-493
4. Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450
5. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136
6. Kusaba T, Okigaki M, Matui A et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci USA 2010; 107: 19308-19313
7. Heijboer AC, Levitus M, Vervloet MG et al. Determination of fibroblast growth factor 23. Ann Clin Biochem 2009; 46: 338-340
8. Heijboer AC, Blankenstein MA, Kema IP et al. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012; 58: 543-548
9. Yamazaki Y, Imura A, Urakawa I et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 2010; 398: 513-518
10. Devaraj S, Syed B, Chien A et al. Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease. Am J Clin Pathol 2012; 137: 479-485
11. Seiler S, Wen M, Roth HJ et al. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 2013; 83: 121-128
12. Yokoyama K, Imura A, Ohkido I et al. Serum soluble alphaklotho in hemodialysis patients. Clin Nephrol 2012; 77: 347-351
13. Carpenter TO, Insogna KL, Zhang JH et al. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 2010; 95: E352-E357
14. Komaba H, Koizumi M, Tanaka H et al. Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2012; 27: 1967-1969
15. Pavik I, Jaeger P, Ebner L et al. Soluble klotho and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2012; 7: 248-257
16. Akimoto T, Shiizaki K, Sugase T et al. The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. Clin Exp Nephrol 2012; 16: 442-447
17. Akimoto T, Yoshizawa H, Watanabe Y et al. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease. BMC Nephrol 2012; 13: 155
18. Akimoto T, Kimura T, Watanabe Y et al. The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein. Transplant Proc 2013; 45: 134-136
19. Wan M, Smith C, Shah V et al. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Nephrol Dial Transplant 2013; 28: 153-161
20. Kitagawa M, Sugiyama H, Morinaga H et al. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One 2013; 8: e56695
21. Semba RD, Cappola AR, Sun K et al. Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc 2011; 59: 1596-1601
22. Pavik I, Jaeger P, Ebner L et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 2013; 28: 352-359